TRIA Orthopaedic Center
Bloomington, Minnesota, 55431, United States
Location status: Recruiting
NCT Number: NCT03804853
Reverse total shoulder arthroplasty (RTSA) has been successful in patients with rotator cuff arthropathy, proximal humerus fractures, failed primary total shoulder arthroplasty or failed hemiarthroplasty, and massive irreparable rotator cuff tear. Patients who undergo an RTSA report pain relief and functional range of motion. It has been more than 20 years since the advent of the RTSA construct but an immediate post-operative rehabilitation with active shoulder range of motion has not been prospectively studied in comparison to the traditional post-operative rehabilitation highlighted by Boudreau et al.12 Investigators plan to prospectively follow our patients following RTSA undergoing an immediate active shoulder rehabilitation (IASR) vs traditional rehabilitation in a randomized controlled fashion. Investigators plan to document clinical outcomes, complications and cost effectiveness out to 1 year.
The study will hopefully fulfill the Triple Aim model for HealthPartners by improving the health of the population, improve the experience of each individual, and make healthcare affordable by decreasing the total cost of care.
Interested in participating?
Request Info55 year and older
All sexes
Interventional
Not applicable
Bloomington, Minnesota, 55431, United States
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In-Clinic:
Intra-operative:
Post-operative:
This study will be a non-blinded randomized controlled outcomes study evaluating outcomes at baseline, 2 weeks, 6 weeks, 3 months, 6 months, and 1 year post-operatively from a primary reverse total shoulder arthroplasty with two different post-operative physical rehabilitation protocols. There will be 2 groups, one undergoing the immediate active shoulder physical therapy protocol consisting of four quadrant stretches and full active motion of the shoulder from post op day 1 in the hospital. The second group will follow the traditional TRIA physical therapy protocol consisting of PT (standard of care) followed by a gradual return to active range of motion of the shoulder beginning by week 6, calling for 18 physical therapy visits. The physical therapy will occur where the patient is most comfortable receiving it.
Time frame: Pre-operatively
Time frame: 2 weeks
Time frame: 3 months
Time frame: 6 months
Time frame: 1 year
Time frame: Pre-operatively
Time frame: 2 weeks
Time frame: 3 months
Time frame: 6 months
Time frame: 1 year
Time frame: Pre-operatively
Time frame: 2 weeks
Time frame: 3 months
Time frame: 6 months
Time frame: 1 year
Time frame: Pre-operatively, 3 months, 6 months, 1 year post-operatively
Time frame: 3 months
Time frame: 6 months
Time frame: 1 year
Time frame: 1 year
Determination if a tear is present.
Time frame: 1 Year
Count of number of visits.
Contact information is provided by the study sponsor or research team.
HealthPartners Institute
Other
Immediate Accelerated Shoulder Rehabilitation Versus a Standard Protocol Following Reverse Total Shoulder Arthroplasty: A Randomized Controlled Trial
Acronym: RTSA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04449146
Arthropathy Shoulder, Shoulder Osteoarthritis
Brest, France
View Trial DetailsNCT04984291
Arthralgia, Fractures, Bone
Irvine, California, United States
View Trial DetailsNCT06381791
Rotator Cuff Injuries, Rupture
Houston, Texas, United States
View Trial DetailsNCT05675618
Arthritis, Hip Osteoarthritis
New York, United States
View Trial Details